U.S. Oral Solid Dosage Contract Manufacturing Market (2025 - 2030) Size, Share & Trends Analysis Report By Product, By Mechanism (Immediate Release, Delayed Release), By End Use, By Country And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Mechanism
                        1.2.3. End Use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Oral Solid Dosage Contract Manufacturing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. U.S. Oral Solid Dosage Contract Manufacturing Market: Product Business Analysis
                    4.1. Product Market Share, 2024 & 2030
                    4.2. Product Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Tablets
                        4.4.1. Tablets Market, 2018 - 2030 (USD Million)
                    4.5. Capsules
                        4.5.1. Capsules Market, 2018 - 2030 (USD Million)
                    4.6. Powders
                        4.6.1. Powders Market, 2018 - 2030 (USD Million)
                    4.7. Granules
                        4.7.1. Granules Market, 2018 - 2030 (USD Million)
                    4.8. Others
                        4.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Oral Solid Dosage Contract Manufacturing Market: Mechanism Business Analysis
                    5.1. Mechanism Market Share, 2024 & 2030
                    5.2. Mechanism Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
                    5.4. Immediate Release
                        5.4.1. Immediate Release Market, 2018 - 2030 (USD Million)
                    5.5. Delayed Release
                        5.5.1. Delayed Release Market, 2018 - 2030 (USD Million)
                    5.6. Controlled Release
                        5.6.1. Controlled Release Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Oral Solid Dosage Contract Manufacturing Market: End Use Business Analysis
                    6.1. End Use Market Share, 2024 & 2030
                    6.2. End Use Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    6.4. Large Size Companies
                        6.4.1. Large Size Companies Market, 2018 - 2030 (USD Million)
                    6.5. Medium & Small Size Companies
                        6.5.1. Medium & Small Size Companies Market, 2018 - 2030 (USD Million)
                    6.6. Others
                        6.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. Catalent, Inc (Novo Holdings A/S)
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. Lonza
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. AbbVie Inc.
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Aenova Group
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Adare Pharma Solutions
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Boehringer Ingelheim International GmbH
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Product Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Jubilant Pharmova Limited
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Product Benchmarking
                            7.5.7.4. Strategic Initiatives
                        7.5.8. Patheon Pharma Services (Thermo Fisher Scientific Inc.)
                            7.5.8.1. Overview
                            7.5.8.2. Financial Performance
                            7.5.8.3. Product Benchmarking
                            7.5.8.4. Strategic Initiatives
                        7.5.9. Recipharm AB
                            7.5.9.1. Overview
                            7.5.9.2. Financial Performance
                            7.5.9.3. Product Benchmarking
                            7.5.9.4. Strategic Initiatives
                        7.5.10. CordenPharma
                            7.5.10.1. Overview
                            7.5.10.2. Financial Performance
                            7.5.10.3. Product Benchmarking
                            7.5.10.4. Strategic Initiatives
                        7.5.11. Siegfried Holding AG
                            7.5.11.1. Overview
                            7.5.11.2. Financial Performance
                            7.5.11.3. Product Benchmarking
                            7.5.11.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. oral solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. oral solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 5 U.S. oral solid dosage contract manufacturing market, by mechanism, 2018 - 2030 (USD Million)
Table 6 U.S. oral solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. oral solid dosage contract manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and mechanism outlook (USD Million)
Fig. 10 End use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 U.S. oral solid dosage contract manufacturing market dynamics
Fig. 13 U.S. oral solid dosage contract manufacturing market: Porter’s five forces analysis
Fig. 14 U.S. oral solid dosage contract manufacturing market: PESTLE analysis
Fig. 15 U.S. oral solid dosage contract manufacturing market: Product segment dashboard
Fig. 16 U.S. oral solid dosage contract manufacturing market: Product market share analysis, 2024 & 2030
Fig. 17 Tablets market, 2018 - 2030 (USD Million)
Fig. 18 Capsules market, 2018 - 2030 (USD Million)
Fig. 19 Powders market, 2018 - 2030 (USD Million)
Fig. 20 Granules market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 U.S. oral solid dosage contract manufacturing market: Mechanism segment dashboard
Fig. 23 U.S. oral solid dosage contract manufacturing market: Mechanism market share analysis, 2024 & 2030
Fig. 24 Immediate release market, 2018 - 2030 (USD Million)
Fig. 25 Delayed release market, 2018 - 2030 (USD Million)
Fig. 26 Controlled release market, 2018 - 2030 (USD Million)
Fig. 27 U.S. oral solid dosage contract manufacturing market: End use segment dashboard
Fig. 28 U.S. oral solid dosage contract manufacturing market: End use market share analysis, 2024 & 2030
Fig. 29 Large size companies market, 2018 - 2030 (USD Million)
Fig. 30 Medium & small size companies market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Company categorization
Fig. 33 Company market position analysis
Fig. 34 Strategic framework